MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617090453 A) filed by Lifetech Scientific Shenzhen Co. , Ltd. on July 24, 2026, for Endoluminal Stent And Stent System.
Inventors include Lin, Zhipeng; and Wang, Wan.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: An endoluminal stent and a stent system. The endoluminal stent (100) comprises a stent main body (10), a controlled-release structure (30) and a development assembly (40). The controlled-release structure (30) comprises a restraining unit (31) and a restraining point (33). The endoluminal stent (100) comprises a first region (100a) and a second region (100b) in a circumferential direction. It is defined that in a state where the endoluminal stent (100) naturally expands, a region of the endoluminal stent in the circumferential direction that can be spanned by the restraining unit (31) is the first region (100a), and a region in the circumferential direction that cannot be spanned by the restraining unit is the second region (100b). The restraining point (33) is arranged in the second region (100B), and the development assembly (40) is configured to indicate the position of the restraining point (33) in the circumferential direction. By providing the development assembly (40) to indicate the position of the restraining point (33) in the circumferential direction, the endoluminal stent (100) can be prevented from placing the second region, which is traversed by a limiting rod (73) on a lesser curvature side of a blood vessel when a controlled-release state is to be deactivated, thereby avoiding distal endoleak.
Disclaimer: Curated by HT Syndication.
